Literature DB >> 12650804

Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications.

Henry T Lynch1, Rodney J Taylor, Jane F Lynch, Joseph A Knezetic, Ali Barrows, Riccardo Fodde, Juul Wijnen, Anja Wagner.   

Abstract

OBJECTIVE: We report a multigeneration family where colorectal cancer and cancer of multiple diverse anatomic sites, inclusive of transitional cell carcinoma of the upper uroepithelial tract, were manifested in several relatives.
METHODS: A specific pattern of cancer of the colorectum, endometrium, ovary, small bowel, and transitional cell carcinoma, with a vertical distribution of this cancer phenotype through multiple generations, was consonant with a diagnosis of hereditary nonpolyposis colorectal cancer.
RESULTS: Germline mutation testing identified the MSH2 mutation, which segregated with the cancer phenotype. This family study clearly demonstrates the value of genetic testing in the management and treatment decision process.
CONCLUSIONS: We document, perhaps for the first time, how molecular genetic testing in hereditary nonpolyposis colorectal cancer can aid in the identification of a potential renal transplant donor for a relative with the MSH2 mutation who is experiencing renal insufficiency secondary to transitional cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650804     DOI: 10.1111/j.1572-0241.2003.07329.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  5 in total

1.  Predictive genetic testing of a bone marrow recipient-ethical issues involving unexpected results, gender issues, test accuracy, and implications for the donor.

Authors:  A Sexton; L Rawlings; M Jenkins; I Winship
Journal:  J Genet Couns       Date:  2013-08-30       Impact factor: 2.537

2.  Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis.

Authors:  Laleh Ehsani; Adeboye O Osunkoya
Journal:  Tumour Biol       Date:  2014-05-30

3.  Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

Authors:  Kelly L Stratton; Shaheen Alanee; Emily A Glogowski; Kasmintan A Schrader; Rohini Rau-Murthy; Robert Klein; Paul Russo; Jonathan Coleman; Kenneth Offit
Journal:  Urol Oncol       Date:  2015-12-23       Impact factor: 3.498

4.  Two novel germline mutations of MLH1 and investigation of their pathobiology in hereditary non-polyposis colorectal cancer families in China.

Authors:  Chao-Fu Wang; Xiao-Yan Zhou; Tai-Ming Zhang; Ye Xu; San-Jun Cai; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

5.  Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.

Authors:  R S van der Post; L A Kiemeney; M J L Ligtenberg; J A Witjes; C A Hulsbergen-van de Kaa; D Bodmer; L Schaap; C M Kets; J H J M van Krieken; N Hoogerbrugge
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.